Was the Synopsys (SNPS) CFO’s share sale made under a trading plan?

Yes. The filing states the transactions were effected under a Rule 10b5-1 trading plan adopted on January 13, 2026. Such pre-arranged plans automate trades over time, indicating the timing of this sale was scheduled rather than a discretionary market-timing decision.

What is the significance of the 17,752-share transfer in the Synopsys (SNPS) filing?

A footnote explains the reporting person transferred 17,752 shares into the Karl and Shelagh Glaser Revocable Trust. The transfer is described as exempt from Section 16 under Rule 16a-13, and these shares are now held indirectly through that revocable trust.

Synopsys CFO sells 3,394 shares under plan

Q: What insider transaction did Synopsys (SNPS) CFO Shelagh Glaser report?

Synopsys CFO Shelagh Glaser reported selling 3,394 shares of Common Stock in an open-market transaction. The weighted average sale price was about $450.02 per share, and the sale was executed indirectly through a revocable trust associated with Glaser.

Q: How many Synopsys (SNPS) shares does CFO Shelagh Glaser hold after this Form 4?

After the reported transactions, Shelagh Glaser held 14,358 shares indirectly through the Karl and Shelagh Glaser Revocable Trust and 629 shares directly. These holdings figures come from the Form 4’s post-transaction ownership columns for indirect and direct Common Stock positions.

Q: What price range were Synopsys (SNPS) shares sold for in this Form 4?

The Form 4 notes a weighted average sale price of about $450.02 per share. Footnotes explain the 3,394 shares were sold in multiple transactions at prices ranging from $450.00 to $457.95, with detailed breakdowns available upon request from the issuer.

Synopsys CFO Shelagh Glaser reported an open-market sale of 3,394 shares of Common Stock at a weighted average price of about $450.02 per share, executed through a trust.

Filing Impact

(Very High)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Synopsys CFO Shelagh Glaser reported an open-market sale of 3,394 shares of Common Stock at a weighted average price of about $450.02 per share, executed through a trust. The transactions were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on January 13, 2026. After the sale, Glaser indirectly held 14,358 shares through the Karl and Shelagh Glaser Revocable Trust and directly held 629 shares. A footnote also describes a prior transfer of 17,752 shares into this revocable trust, noted as exempt under Rule 16a-13.

Insider Trade Summary 10b5-1

Net Seller: 3,394 shares

Net Sell 2 txns

Insider Glaser Shelagh

Role CFO

Sold 3,394 shs ($1.53M)

Type	Security	Shares	Price	Value
Sale	Common Stock	3,394	$450.0211	$1.53M
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 14,358 shares (Indirect, by Trust); Common Stock — 629 shares (Direct)

Footnotes (3)

F1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted January 13, 2026.
F2. Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $450.00 to $457.95. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
F3. The reporting person transferred 17,752 shares into the Karl and Shelagh Glaser Revocable Trust. The Transfer is exempt from Section 16 by virtue of Rule 16a-13. The shares are indirectly held by the reporting person through the Karl and Shelagh Glaser Revocable Trust.

Key Figures

Shares sold: 3,394 shares Weighted average sale price: $450.0211 per share Sale price range: $450.00 to $457.95 per share +3 more

6 metrics

Shares sold 3,394 shares Open-market sale of Synopsys Common Stock on June 12, 2026

Weighted average sale price $450.0211 per share Average price for the 3,394 shares sold

Sale price range $450.00 to $457.95 per share Price range of multiple sale transactions

Indirect holdings after transaction 14,358 shares Common Stock held indirectly by trust after sale

Direct holdings after transaction 629 shares Common Stock held directly after reported transactions

Shares transferred to trust 17,752 shares Prior transfer into Karl and Shelagh Glaser Revocable Trust

Key Terms

Rule 10b5-1 trading plan, Section 16, Rule 16a-13, Karl and Shelagh Glaser Revocable Trust

4 terms

Rule 10b5-1 trading plan regulatory

"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted January 13, 2026."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Section 16 regulatory

"The Transfer is exempt from Section 16 by virtue of Rule 16a-13."

Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.

Rule 16a-13 regulatory

"The Transfer is exempt from Section 16 by virtue of Rule 16a-13."

Karl and Shelagh Glaser Revocable Trust financial

"The reporting person transferred 17,752 shares into the Karl and Shelagh Glaser Revocable Trust."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Synopsys (SNPS) CFO Shelagh Glaser report?

Synopsys CFO Shelagh Glaser reported selling 3,394 shares of Common Stock in an open-market transaction. The weighted average sale price was about $450.02 per share, and the sale was executed indirectly through a revocable trust associated with Glaser.

How many Synopsys (SNPS) shares does CFO Shelagh Glaser hold after this Form 4?

After the reported transactions, Shelagh Glaser held 14,358 shares indirectly through the Karl and Shelagh Glaser Revocable Trust and 629 shares directly. These holdings figures come from the Form 4’s post-transaction ownership columns for indirect and direct Common Stock positions.

What price range were Synopsys (SNPS) shares sold for in this Form 4?

The Form 4 notes a weighted average sale price of about $450.02 per share. Footnotes explain the 3,394 shares were sold in multiple transactions at prices ranging from $450.00 to $457.95, with detailed breakdowns available upon request from the issuer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/15/2026 - 02:03 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Glaser Shelagh

(Last)

(First)

(Middle)

675 ALMANOR AVENUE

(Street)

SUNNYVALE

CALIFORNIA

94085

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SYNOPSYS INC [ SNPS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/12/2026		S⁽¹⁾		3,394	D	$450.0211⁽²⁾	14,358⁽³⁾	I	by Trust
Common Stock								629	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted January 13, 2026.

2. Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $450.00 to $457.95. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.

3. The reporting person transferred 17,752 shares into the Karl and Shelagh Glaser Revocable Trust. The Transfer is exempt from Section 16 by virtue of Rule 16a-13. The shares are indirectly held by the reporting person through the Karl and Shelagh Glaser Revocable Trust.

	By: POA pursuant Mary Lai For: Shelagh Glaser	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR